Natus Medical Inc

Find Ratings Reports
BABY : NASDAQ : Health Care
$35.35 up 0.8 | 2.32%
Today's Range: 34.45 - 35.45
Avg. Daily Volume: 359000.0
09/22/17 - 4:00 PM ET

Financial Analysis


NATUS MEDICAL INC's gross profit margin for the second quarter of its fiscal year 2017 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. NATUS MEDICAL INC is extremely liquid. Currently, the Quick Ratio is 2.25 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.

During the same period, stockholders' equity ("net worth") has increased by 7.64% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY17 Q2 FY16
Net Sales ($mil)122.2395.96
EBITDA ($mil)9.1219.19
EBIT ($mil)2.0415.01
Net Income ($mil)-5.0310.51


Balance Sheet Q2 FY17 Q2 FY16
Cash & Equiv. ($mil)80.396.28
Total Assets ($mil)662.59486.09
Total Debt ($mil)109.510.0
Equity ($mil)426.49396.22


Profitability Q2 FY17 Q2 FY16
Gross Profit Margin60.6361.95
EBITDA Margin7.4519.99
Operating Margin1.6715.65
Sales Turnover0.670.78
Return on Assets2.847.92
Return on Equity4.429.72
Debt Q2 FY17 Q2 FY16
Current Ratio3.333.18
Debt/Capital0.20.02
Interest Expense1.280.1
Interest Coverage1.59153.2


Share Data Q2 FY17 Q2 FY16
Shares outstanding (mil)33.1532.94
Div / share0.00.0
EPS-0.150.32
Book value / share12.8712.03
Institutional Own % n/a n/a
Avg Daily Volume377996.0349299.0

Valuation


HOLD. NATUS MEDICAL INC's P/E ratio indicates a significant premium compared to an average of 48.70 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 24.88. To use another comparison, its price-to-book ratio of 2.77 indicates a discount versus the S&P 500 average of 3.10 and a significant discount versus the industry average of 4.90. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
BABY 62.46 Peers 48.70   BABY 23.46 Peers 37.09

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

BABY is trading at a significant premium to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

BABY is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
BABY 18.03 Peers 33.41   BABY 1.97 Peers 1.03

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

BABY is trading at a significant discount to its peers.

 

Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

BABY trades at a significant premium to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
BABY 2.77 Peers 4.90   BABY -51.29 Peers 47.56

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

BABY is trading at a significant discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, BABY is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
BABY 2.65 Peers 5.32   BABY 17.91 Peers 15.38

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

BABY is trading at a significant discount to its industry on this measurement.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

BABY has a sales growth rate that exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades